We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.62B
AUM Growth
-$84.4M
Cap. Flow
-$358M
Cap. Flow %
-9.89%
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$254M
2
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$46.3M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$30.5M
4
VBIL
Vanguard 0-3 Month Treasury Bill ETF
VBIL
+$29.2M
5
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$24.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
MSFT icon
Microsoft
MSFT
+$46.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
4
NVDA icon
NVIDIA
NVDA
+$27.6M
5
PLTR icon
Palantir
PLTR
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 7.48%
3 Consumer Discretionary 6.48%
4 Healthcare 6.28%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLNH icon
2901
Soluna Holdings
SLNH
$205M
$31.3K ﹤0.01%
+13,310
New +$11.2K
ETD icon
2902
Ethan Allen Interiors
ETD
$575M
$31.1K ﹤0.01%
1,056
-1,998
-65% -$59K
XPRO icon
2903
Expro Ltd
XPRO
$2.07B
$31.1K ﹤0.01%
2,617
-9,325
-78% -$101K
NEOG icon
2904
Neogen
NEOG
$2.5B
$31.1K ﹤0.01%
5,439
-18,146
-77% -$96.9K
GMAB icon
2905
Genmab
GMAB
$19.3B
$31K ﹤0.01%
1,012
-45,641
-98% -$1.11M
ARHS icon
2906
Arhaus
ARHS
$1.37B
$31K ﹤0.01%
2,912
-4,479
-61% -$47.1K
TMP icon
2907
Tompkins Financial
TMP
$1.44B
$30.9K ﹤0.01%
467
-1,538
-77% -$103K
MYGN icon
2908
Myriad Genetics
MYGN
$309M
$30.9K ﹤0.01%
4,275
-6,307
-60% -$37.4K
INVX
2909
Innovex International
INVX
$2.15B
$30.9K ﹤0.01%
1,667
-1,856
-53% -$30.9K
TARS icon
2910
Tarsus Pharmaceuticals
TARS
$3.07B
$30.9K ﹤0.01%
520
-3,525
-87% -$174K
DGRO icon
2911
iShares Core Dividend Growth ETF
DGRO
$43.9B
$30.8K ﹤0.01%
453
-1,198
-73% -$79.2K
ZBIO
2912
Zenas BioPharma
ZBIO
$1.98B
$30.8K ﹤0.01%
1,388
-1,158
-45% -$18.9K
DXD icon
2913
ProShares UltraShort Dow 30
DXD
$42.6M
$30.8K ﹤0.01%
1,400
+1,102
+370% +$25.8K
AU icon
2914
AngloGold Ashanti
AU
$48.1B
$30.7K ﹤0.01%
437
-212
-33% -$11.9K
HSTM icon
2915
HealthStream
HSTM
$849M
$30.7K ﹤0.01%
1,088
-1,319
-55% -$36.3K
PLRX icon
2916
Pliant Therapeutics
PLRX
$66.3M
$30.7K ﹤0.01%
20,749
-2,561
-11% -$3.91K
CAPR icon
2917
Capricor Therapeutics
CAPR
$244M
$30.7K ﹤0.01%
4,253
-2,495
-37% -$18.4K
SVC
2918
Service Properties Trust
SVC
$1.06B
$30.5K ﹤0.01%
2,251
-1,347
-37% -$18.3K
GRC icon
2919
Gorman-Rupp
GRC
$2.15B
$30.5K ﹤0.01%
657
-1,396
-68% -$57.9K
HYMC icon
2920
Hycroft Mining Holding Corp
HYMC
$2.48B
$30.4K ﹤0.01%
+4,904
New +$21.8K
GOOS
2921
Canada Goose Holdings
GOOS
$850M
$30.3K ﹤0.01%
2,200
+1,490
+210% +$19.3K
FISI icon
2922
Financial Institutions
FISI
$825M
$30.3K ﹤0.01%
1,115
-9,945
-90% -$265K
HCSG icon
2923
Healthcare Services Group
HCSG
$1.43B
$30.3K ﹤0.01%
1,799
-8,460
-82% -$126K
LILA icon
2924
Liberty Latin America Class A
LILA
$1.69B
$30.3K ﹤0.01%
5,374
-1,023
-16% -$5.12K
LYEL icon
2925
Lyell Immunopharma
LYEL
$347M
$30.2K ﹤0.01%
1,858
-245
-12% -$2.8K
115 116
117
118 119

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.

  • Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
  • Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
  • Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.